NXS 0.00% 20.0¢ next science limited

the positive news, page-10

  1. 10,865 Posts.
    lightbulb Created with Sketch. 1322
    You are not listening to the market, that's why you consistently make errors like Patterson, Wilson and Hartleys.. if you work for one these losers then what can I say?

    NXS is valued today at $250 million with debt. If they manage to pay down debt for the LT loan facility and receive the $70 million gross cash flow in full thus ~$300-330 million valuation to me seems fair which is LT's Capex. $70 million pre tax cashflow is approx $15 million net.

    Without knowing the true value of Crux & Echuca I added $100 million [and being generous] to its underlying valuation. Therefore $400 million valuation is GENEROUS.

    NXS require a MINIMUM of $110 million to avoid paying interest on its notes... so a raising of $150-$200 million in order to complete LT and be very close to debt free seems very close to the mark. If it is to raise capital may as well go all out and pay down all debt and all future cashflow from LT will go to its coffers.

    After two years; when there is PROVEN steady cash flow from LT then it will be time to re-finance in order to build up Echuca or Crux. Not before.
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.000(0.00%)
Mkt cap ! $58.43M
Open High Low Value Volume
19.0¢ 20.0¢ 19.0¢ $2.208K 11.54K

Buyers (Bids)

No. Vol. Price($)
1 97393 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 35987 2
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.